325 related articles for article (PubMed ID: 11034083)
1. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
[TBL] [Abstract][Full Text] [Related]
2. Inadequate production of hematopoietic growth factors in hairy cell leukemia: up-regulation of interleukin 6 by recombinant IFN-alpha in vitro.
Schwarzmeier JD; Hilgarth M; Nguyen ST; Shehata M; Gruber G; Spittler A; Willheim M; Boltz-Nitulescu G; Höcker P; Berger R
Cancer Res; 1996 Oct; 56(20):4679-85. PubMed ID: 8840984
[TBL] [Abstract][Full Text] [Related]
3. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
Lepe-Zuniga JL; Quesada JR; Baron S; Reuben J; Gutterman JU
Hematol Pathol; 1987; 1(3):157-65. PubMed ID: 3150846
[TBL] [Abstract][Full Text] [Related]
4. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
5. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
Vedantham S; Gamliel H; Golomb HM
Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
8. MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.
Meier V; Mihm S; Ramadori G
J Med Virol; 2000 Nov; 62(3):318-26. PubMed ID: 11055241
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
[TBL] [Abstract][Full Text] [Related]
10. Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters.
Hiraoka A; Golomb HM
J Biol Response Mod; 1986 Jun; 5(3):270-81. PubMed ID: 3723140
[TBL] [Abstract][Full Text] [Related]
11. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
Aswald JM; Lipton JH; Messner HA
Cytokines Cell Mol Ther; 2002 Dec; 7(2):75-82. PubMed ID: 12607798
[TBL] [Abstract][Full Text] [Related]
12. Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
Zinzani PL; Lauria F; Salvucci M; Rondelli D; Raspadori D; Bendandi M; Magagnoli M; Tura S
Haematologica; 1997; 82(2):152-5. PubMed ID: 9175317
[TBL] [Abstract][Full Text] [Related]
13. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
[TBL] [Abstract][Full Text] [Related]
14. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
15. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of response of rheumatoid synovium cell subsets to interleukin-18 in relation to differential interleukin-18 receptor expression.
Kawashima M; Miossec P
Arthritis Rheum; 2003 Mar; 48(3):631-7. PubMed ID: 12632414
[TBL] [Abstract][Full Text] [Related]
17. Influence of interferon-alpha on the expression of cellular oncogenes in primary chronic lymphocytic leukemia cells.
Einhorn S; Showe L; Ostlund L; Juliusson G; Robèrt KH; Gahrton G; Croce C
Oncogene Res; 1988; 3(1):39-49. PubMed ID: 3060797
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
Shimazaki T; Honda M; Kaneko S; Kobayashi K
Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
[TBL] [Abstract][Full Text] [Related]
19. IFN-alpha in vivo enhances tumor necrosis factor receptor levels on hairy cells.
Billard C; Sigaux F; Wietzerbin J
J Immunol; 1990 Sep; 145(6):1713-8. PubMed ID: 2167909
[TBL] [Abstract][Full Text] [Related]
20. Recombinant interferon alpha-2 modulates hairy cell phenotype "in vitro".
Fattorossi A; Dolei A; Pizzolo JG; Cafolla A; Mandelli F; Dianzani F
J Biol Regul Homeost Agents; 1987; 1(2):87-92. PubMed ID: 3504087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
